Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events

Author:

Healy Aileen M.1,Pickard Michael D.1,Pradhan Aruna D.1,Wang Yunmei1,Chen Zhiping1,Croce Kevin1,Sakuma Masashi1,Shi Can1,Zago Alexandre C.1,Garasic Joseph1,Damokosh Andrew I.1,Dowie Tracy L.1,Poisson Louis1,Lillie James1,Libby Peter1,Ridker Paul M1,Simon Daniel I.1

Affiliation:

1. From Millennium Pharmaceuticals, Inc (A.M.H., M.D.P., A.I.D., T.L.D., L.P., J.L.), Cambridge, Mass; Cardiovascular Division (A.D.P., Y.W., Z.C., K.C., M.S., C.S., A.C.Z., P.L., P.M.R., D.I.S.), the Center for Cardiovascular Disease Prevention (A.D.P., P.M.R.), and Donald W. Reynolds Center for Clinical Cardiovascular Research (A.D.P., P.L., P.M.R.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and Cardiology Division (J.G.), Massachusetts General Hospital, Harvard Medical...

Abstract

Background— Platelets participate in events that immediately precede acute myocardial infarction. Because platelets lack nuclear DNA but retain megakaryocyte-derived mRNAs, the platelet transcriptome provides a novel window on gene expression preceding acute coronary events. Methods and Results— We profiled platelet mRNA from patients with acute ST-segment–elevation myocardial infarction (STEMI, n=16) or stable coronary artery disease (n=44). The platelet transcriptomes were analyzed and single-gene models constructed to identify candidate genes with differential expression. We validated 1 candidate gene product by performing a prospective, nested case-control study (n=255 case-control pairs) among apparently healthy women to assess the risk of future cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death) associated with baseline plasma levels of the candidate protein. Platelets isolated from STEMI and coronary artery disease patients contained 54 differentially expressed transcripts. The strongest discriminators of STEMI in the microarrays were CD69 (odds ratio 6.2, P <0.001) and myeloid-related protein-14 (MRP-14; odds ratio 3.3, P =0.002). Plasma levels of MRP-8/14 heterodimer were higher in STEMI patients (17.0 versus 8.0 μg/mL, P <0.001). In the validation study, the risk of a first cardiovascular event increased with each increasing quartile of MRP-8/14 ( P trend <0.001) such that women with the highest levels had a 3.8-fold increase in risk of any vascular event ( P <0.001). Risks were independent of standard risk factors and C-reactive protein. Conclusions— The platelet transcriptome reveals quantitative differences between acute and stable coronary artery disease. MRP-14 expression increases before STEMI, and increasing plasma concentrations of MRP-8/14 among healthy individuals predict the risk of future cardiovascular events.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3